Sign in to continue:

Monday, January 26th, 2026

Wilmar International Stock Analysis: Bullish Reversal, Technical Buy, and Upgraded Target Price for 2025

Broker Name: CGS International
Date of Report: October 9, 2025
Excerpt from CGS International report.

  • Gold price surge: Spot gold broke above \$4,000/oz for the first time amid US economic concerns, government shutdown fears, and strong demand for safe-haven assets; central banks and ETFs have driven the rally.
  • Wilmar International outlook: Wilmar’s recent share price drop is believed to have priced in the Indonesian Supreme Court fine; stronger soybean crushing margins in China could support upcoming profits. The broker upgraded Wilmar to “Add” with a target price of S\$3.30, citing potential earnings normalization in FY26F-27F and technical indicators suggesting a bullish mean-reversion.

Report Summary

  • Gold has surged on global economic uncertainty, monetary easing, and increased ETF inflows, significantly outperforming equities.
  • Wilmar International is expected to recover from recent setbacks, with improved margins and legal issues largely priced in; the broker recommends accumulating Wilmar shares for potential upside.

Above is an excerpt from a report by CGS International. Clients of CGS International can be the first to access the full report from the CGS International website : https://www.cgs-cimb.com

CICT Q3 2024 Results: Strong Rental Reversions but Moderation Expected in FY25

Comprehensive Analysis of CapitaLand Integrated Commercial Trust and Peer Comparisons OCBC Investment Research – 5 November 2024 The latest equity research report from OCBC Investment Research provides an in-depth analysis of CapitaLand Integrated Commercial...

MAS Boost: Dividend-Yielding Banks and REITs Poised for Gains Amid S$5 Billion Liquidity Injection

Singapore – In a bold move aimed at revitalizing Singapore’s stock market, the Monetary Authority of Singapore (MAS) has announced a S$5 billion injection into a new programme designed to boost liquidity by encouraging...

Hyphens Pharma International (HYP) 2025 Outlook: Higher Margins, Portfolio Optimization & Growth Targets in Southeast Asia

CGS International August 20, 2025 Hyphens Pharma International: Strategic Portfolio Shift Drives Margin Growth Despite Revenue Dip Executive Summary: Navigating a Pivotal Transition in Hyphens Pharma International Hyphens Pharma International (SGX: HYP), a leading...